Organogenesis (ORGO) EBITDA (2016 - 2026)
Organogenesis (ORGO) EBITDA from Mar 31, 2016 to Mar 31, 2026. The TTM Organogenesis (ORGO) EBITDA is $19M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Organogenesis (ORGO) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | -10.19% |
| 5 Years TTM | -20.64% |
Annual EBITDA change of Organogenesis (ORGO)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$65M | -207.92% |
| 2025 | $60M | +385.98% |
| 2024 | $12M | -46.28% |
| 2023 | $23M | -18.40% |
| 2022 | $28M | -63.91% |
| 2021 | $78M | +150.48% |
| 2020 | $31M | -219.45% |
| 2019 | -$26M | -45.97% |
| 2018 | -$48M | +2439.47% |
| 2017 | -$1.90M | +18900.00% |
| 2016 | -$10K | -66.67% |
| 2015 | -$30K | N/A |
Comparison Organogenesis (ORGO) five years EBITDA CAGR with competitors
Organogenesis (ORGO) five years EBITDA CAGR is -20.64%.